Custom Truck One SourceNYSE: CTOS

Phase 1/2 data showed a median overall survival ("mOS") of 21.3 months versus a synthetic control of 6.7 months, an increase in T-cell activation, and favorable safety profile for patients receiving INT230-6 alone INVINCIBLE-3 Study is recruiting and expected to enroll 333 patients with leiomyosarcoma, liposarcoma and undeferential pleomorphic sarcoma; authorizations for the INVINCIBLE-3 Study have been received in the U.S., Canada, Europe and Australia SHELTON, Conn. , Nov. 18, 2024 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS), ("Intensity" or "the Company") a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immune system recognition of cancers, today announced that Christian F.

– Long-term follow-up data highlight further reductions in tumor size, increase in ORR with additional CRs, sustained improvement in desmoid tumor symptoms, and consistent safety profile, now with a median duration of therapy of approximately 3 years –

Custom Truck One Source, Inc. (CTOS) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to earnings of $0.04 per share a year ago.

Custom Truck One Source, Inc. (NYSE:CTOS ) Q2 2024 Earnings Conference Call August 2, 2024 5:00 PM ET Company Participants Brian Perman - VP, IR Ryan McMonagle - CEO Chris Eperjesy - CFO Conference Call Participants Justin Hauke - Robert W. Baird Tami Zakaria - JPMorgan Michael Shlisky - D.A.

Custom Truck One Source, Inc. (CTOS) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.05 per share a year ago.

Custom Truck One Source (CTOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Custom Truck One Source, Inc. (CTOS) reported a quarterly loss of $0.06 per share, which was higher than the expected loss of $0.01 per share according to the Zacks Consensus Estimate. This is a decrease from earnings of $0.06 per share in the same quarter last year.

Custom Truck One Source, Inc. (CTOS) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.15 per share a year ago.

Custom Truck One Source, Inc. (NYSE:CTOS ) Q4 2023 Earnings Conference Call March 7, 2024 5:00 PM ET Company Participants Brian Perman - VP, IR Ryan McMonagle - CEO Chris Eperjesy - CFO Conference Call Participants Scott Schneeberger - Oppenheimer Nicole DeBlase - Deutsche Bank Justin Hauke - Robert W. Baird Tami Zakaria - JPMorgan Operator Good afternoon.